Search by Drug Name or NDC
NDC 59746-0448-05 IRBESARTAN 150 mg/1 Details
IRBESARTAN 150 mg/1
IRBESARTAN is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Jubilant Cadista Pharmaceuticals Inc.. The primary component is IRBESARTAN.
MedlinePlus Drug Summary
Irbesartan is used alone or in combination with other medications to treat high blood pressure. It is also used to treat kidney disease caused by diabetes in patients with type 2 diabetes (condition in which the body does not use insulin normally and therefore cannot control the amount of sugar in the blood) and high blood pressure. Irbesartan is in a class of medications called angiotensin II receptor antagonists. It works by blocking the action of certain natural substances that tighten the blood vessels, allowing the blood to flow more smoothly and the heart to pump more efficiently. High blood pressure is a common condition, and when not treated it can cause damage to the brain, heart, blood vessels, kidneys, and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 59746-0448-05Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Irbesartan
Product Information
| NDC | 59746-0448 |
|---|---|
| Product ID | 59746-448_88691191-8b85-44f3-b802-e170d776ad87 |
| Associated GPIs | 36150030000320 |
| GCN Sequence Number | 034468 |
| GCN Sequence Number Description | irbesartan TABLET 150 MG ORAL |
| HIC3 | A4F |
| HIC3 Description | ANTIHYPERTENSIVES, ANGIOTENSIN RECEPTOR ANTAGONIST |
| GCN | 04749 |
| HICL Sequence Number | 015576 |
| HICL Sequence Number Description | IRBESARTAN |
| Brand/Generic | Generic |
| Proprietary Name | IRBESARTAN |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | IRBESARTAN |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 150 |
| Active Ingredient Units | mg/1 |
| Substance Name | IRBESARTAN |
| Labeler Name | Jubilant Cadista Pharmaceuticals Inc. |
| Pharmaceutical Class | Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA203534 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 59746-0448-05 (59746044805)
| NDC Package Code | 59746-448-05 |
|---|---|
| Billing NDC | 59746044805 |
| Package | 500 TABLET in 1 BOTTLE (59746-448-05) |
| Marketing Start Date | 2015-02-24 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |